By Laurence Smith, Greybeard Healthcare Co-Founder
Simon Giffin, Greybeard Healthcare Chief Executive Officer
In this piece, the authors share reflections on the latest megatrends they are seeing within the healthcare sector.
Megatrend #1
PERSONALIZED MEDICINE
The global personalized medicine market is growing four to five times faster than the GDP of most developed countries. It currently stands at $654 billion, and is forecast to reach $1,325 billion within the next ten years (8.1% CAGR) (1).
This rapid embrace of personalized medicine at all stage of healthcare delivery reflects a rare alignment of demand and supply-side factors. Patients now encounter the benefits of personalization in almost all other aspects of their lives as consumers, largely driven by the ability of technology to tailor services to reflect their attitudes and behaviours, and expect the same experience throughout their healthcare journey. And, on the supply side, next-generation technologies enable service providers to design solutions optimized for the unique nature of each patient’s biology and physiology.
As part of Megatrends #1, we expect to see:
- Genetic information held within patient records, to be factored into diagnostic and treatment plans by any healthcare provider.
- Artificial intelligence used to optimize each element of the treatment plan based on quantification of the expected benefits and risks (expected reactions to specific active ingredients, including the dosage and frequency, and calibrating the impact of drug combinations).
- Precision treatments for diabetes and cancer, especially for patients who have been non-responsive to ‘standard’ interventions or pathways.
- Stem cell advancement – with advances in the science there are signs that stem cells, especially bone marrow and adipose derived mesenchymal stem cells will show hope for neuro regenerative treatment and possibly a long-term solution to Parkinson’s, Dementia, Motor Neurone disease and the connectivity in spinal injury rehabilitation. There is still a need for large clinical trials to validate promising research.
Megatrend #2
AWAY FROM THE HOSPITAL
Since the COVID pandemic provided the catalyst for healthcare operators to accelerate the delivery of services in ways that were not reliant on the existence of a single monolithic bricks-and-mortar hospital building, evidence has mounted that ‘hospital at home’ services yield benefits of many different types.
Peer-revised studies have estimated that cost savings can exceed 50% (2); however, this is rarely the single measure. Other advantages include freeing up hospital bed capacity (and therefore reducing the waiting list for surgical procedures requiring an inpatient stay); faster recuperation (due to the comfort of a familiar home environment, surrounded by family members); and a reduction in exposure to hospital-acquired infections.
As part of Megatrend #2, we expect to see:
- The scope of Hospital-at-Home services expanded from its focus on post-operative discharged patients to those requiring hospital-standard care for long-term chronic conditions
- Investment in making many additional categories of medical equipment suitable for home use (for example, infusion, dialysis, respiratory) based on size, portability and durability
- Advances in the patient metrics that can be monitored in real-time outside the hospital setting (for example, via wearables), and the technologies (such as apps) that collate and monitor this data to enable urgent interventions when appropriate
- Changes in long-term investment decisions – do we need to build more physical bedspace or create more virtual wards?
- Reductions in the length of waiting lists in countries where demand outstrips supply
Megatrend #3
SERVICE INTEGRATION
Healthcare is surely the most complex and disparate service provided in a modern economy, typically accounting for at least 10 per cent of GDP (10.7% in Japan, 10.5% in the European Union, 16.7% in the United States) (3).
The American Board of Medical Specialties identifies 40 general specialities and 89 sub-specialities (4), any one of which can be delivered by organizations large or small in the public, private and voluntary sectors. The daunting ecosystem created by all this activity would have been obvious to anyone attending the recent World Health Expo (WHX) in Dubai, which featured a remarkable 4,300 exhibitors from over 180 countries (5). The risks from fragmentation have never been greater, and – as evidenced by a recent research paper – fragmentation can be particularly damaging in the context of healthcare, where is causes “inefficiency, poor quality and governance challenges”(6).
As part of Megatrends #3, we expect to see:
- Further evolution in value-based healthcare practices: Having moved from individual treatment codes to Diagnosis-Related Group (DRG) codes with bundled care, policymakers in the Gukld region and elsewhere are now considering outcome-based care, with possible hybrid capitation plans. The goal is to remove incentives for unnecessary treatment and focus on prevention and the best clinical outcome for patients.
- Public authorities working together to embed consistency and standards around terminology, definitions and calculations, especially relating to symptoms, diagnostics, procedures, and pharmaceuticals.
- The emergence of a small number of globally-accepted, highly secure Cloud-based tools that provide a holistic patient-centered view through consolidating clinical information (including medical histories, vital signs, treatment plans and test results) from multiple sources.
- Protocols for the transfer of patient care from one organization to another to ensure the patient’s best interests are protected at all times.
Megatrend #4
RESOURCE REBALANCING
European Commission analysis suggests that over half of healthcare expenditure within the EU involves acute elective interventions (7). This is putting unprecedented strain on limited resources, due to the cumulative impact of the cost of the operation itself, and (where the procedure was inpatient) the resulting length of stay.
The American Hospital Association estimates that the hospital case-mix index (a measure of the level of patient sickness) rose by about 5% between 2019 and 2024, requiring a larger share of hospital care to be directed to higher-acuity patients with multiple conditions, greater clinical needs and longer stays. AHA concludes that “sicker, more complex patients [require] more staff time, monitoring and specialized treatment” (8).
One further consequence in this ever evolving case-mix change is that hospitals are finding it increasingly challenging to balance resources to ensure quality of care and patient safety is maintained and enhanced in the most efficient manner.
As part of Megatrends #4, we expect to see:
- A shift of resources in favor of ‘population health’ initiatives that focus on maintaining wellness (for example, through eating habits and exercise) rather than treating illness.
- Screening and monitoring programs so that, when conditions such as cancer do arise, they can be treated at an early stage when the required intervention is more straightforward.
- Investment in chronic disease management, using A.I. and other tools to design treatment plans for those suffering from long-term conditions, which reduces the need for repeated inpatient stays.
- Increased use of AI, not only in the space of interviewing and recruitment but also to support capability matching and workforce planning on an ongoing basis.
Megatrend #5
(Gulf States): EQUALITY OF ACCESS
A considerable amount of Greybeard’s current activity involves the Gulf region, where we have observed a major effort to improve access to healthcare services for many categories of patients who, in earlier times, might have been disadvantaged.
One high profile example is the emergence as a major knowledge hub of the Saudi Society for Women’s Health – which, in 2026, will be convening the 5th annual Women’s Heakth Conference, where doctors, researchers and allied healthcare professionals can exchange knowledge and practices which promote this important cause 9; women’s health is also a priority within the Kingdom’s Vision 2030 Transformation Plan. Another is the UAE’s launch, in 2027, of a National Policy for Empowering Persons with Disabilities to enhance social integration, based on the principle that such investment is essential to “the comprehensive and sustainable development of society” 10.
As part of Megatrends #5, we expect to see:
- Health Ministries partnering with the private sector on initiatives to enhance access to specialist services for women and people of determination from lower income groups.
- Investment in the capacity of pediatric services, both within mainstream hospitals and as specialist community-based clinics.
- Women’s health metrics included in national frameworks so that progress can be openly reported.
Greybeard Healthcare will continue to support our clients in further understanding and responding to these Megatrends to be at the forefront of great healthcare leadership. We would be fascinated to hear from operators throughout the healthcare ecosystem who have opinions on these megatrends … and whether there are others which we have overlooked.
Notes
- Precedence Research, ‘Personalized Medicine Market Size, Share, and Trends 2026 to 2035’, 13 March 2026
- Jindal, Shivani; Pietruszka, Brittany; Meears, Rachel; Parris, James; ‘The Boston Hospital At Home Program – a local perspective’, Oxford university Press, 21 December 2023
- World Bank; https://data.worldbank.org/indicator/SH.XPD.CHEX.GD.ZS
- American Board Of Medical Specialties; https://www.abms.org/member-boards/specialty-subspecialty-certificates
- World Health Expo; https://www.worldhealthexpo.com/events
- Mari Tvaliashivli et all, ‘Exploring the risks of fragmentation in health care markets – An analysis of inpatient care in Georgia’, Social Science & Medicine, Volume 362, December 2024
- Eurostat,’ Major functions of healthcare expenditure, 2023 (% of current healthcare expenditure) HCE2025.png
- American Hospital Association, ‘Costs of Caring’, March 2026
- Welcome message by Dr. Sameer Sendy, Conference President, President of Saudi Society of Woman Health, https://www.iscgo-ksa.com/
- UAE Permanent Committee foir Human Rights; https://pchr.gov.ae/en/priority-details/persons-with-disabilities
Thank you, Lawrence and Simon, for an excellent and very timely compilation of healthcare megatrends.
Building on your insights, I’d like to suggest a few additional, GCC-specific emerging megatrends and cross-cutting themes:
1) Health Data Sovereignty and AI Regulation
We are seeing strong moves to keep health data within national borders, alongside the development of local AI regulations, sandboxes, and certification schemes for clinical AI tools.
2) Climate, Environment, and Health
There is growing recognition of the health impacts of heat stress, air quality, and climate-related events—particularly for outdoor and vulnerable workers—driving interest in surveillance, early warning systems, and stronger occupational protections.
3) Maturing Public–Private Partnerships (PPPs)
PPPs are evolving from traditional outsourcing models to more sophisticated, risk-sharing and outcome-based contracts, especially in specialized services such as oncology, rehabilitation, and dialysis.
4) Health Security and Local Manufacturing
In the post-COVID era, there is renewed emphasis on local and regional manufacturing of medicines, vaccines, and critical supplies, as well as on building resilient supply chains and strategic stockpiles.
5) Digital Health as an Export Capability
GCC countries are increasingly positioning themselves not only as importers but also as exporters of digital health and AI solutions to wider MENA, Africa, and Asia, aiming to become regional innovation hubs.
Overall, your article provides a strong and coherent framework. In the GCC context, these megatrends are likely to be shaped by ambitious national visions, strong regulatory levers, and a distinctive demographic and workforce profile. This creates a real opportunity for the region to move rapidly from concept to scaled implementation—particularly where policy, payment, data infrastructure, and workforce development are aligned.
Thank you again for stimulating such an important discussion. I hope these additional GCC-focused observations are useful as you continue to refine and extend your thinking on the future of healthcare in the region.